Downloadable
The use of enzymes as catalysts in chemical reactions offer several advantages for pharmaceutical manufacturing over traditional chemical production routes. Benefits include high selectivity, product purity and mild reaction conditions that reduces energy consumption and waste whilst removing the use of hazardous chemicals.
Ingenza has a proven track record delivering several scalable biocatalytic processes, and in this white paper, Reuben Carr, Head of Chemical Biology considers the key benefits that alternative biocatalysis approaches provide over chemical catalysis for industrial applications.
To access this content, please fill in your details below.